BIOND Solutions B.V
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
BIOND Solutions B.V - overview
Established
2017
Location
Delft, -, Netherlands
Primary Industry
Biotechnology
About
Based in the Netherlands, and founded in 2017 by its CEO Dr. Cinzia Silvestri, CTO Dr. Nikolas Gaio, and. William F.
G. Solano, BIOND Solutions B. V, also known as Bi/ond, operates as an organ-on-chip platform. In March 2022, raised EUR 3.
7 million in series A funding led by new investor FORWARD. one Venture Capital. BIOND Solutions B. V operates as a biotechnology research company that provides complex 3-dimensional tissues such as inCHIPit™ (open well microfluidic channel) and comPLATE™.
The open well inCHIPit™ consists of tissue sample types such as microtissues, organoids, patient-derived samples, and cell monolayers. The tissue comPLATE™ is used to perform process analysis such as cell morphology, viability, medium analysis, and end assays such as histology, qPCR (quantitative polymerase chain reaction), protein analysis, fixed cells, and staining. It also provides hardware solutions to improve medical treatments for humans.
Current Investors
FORWARD.one Venture Capital
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.gobiond.com
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.